Marinus Pharmaceuticals Inc

NASDAQ:MRNS  
4.22
-0.01 (-0.24%)
7:43:32 PM EDT: $4.35 +0.13 (+3.08%)
Earnings Announcements

Marinus Pharmaceuticals Inc Reports Q3 EPS Of $1.89

Published: 11/07/2022 21:41 GMT
Marinus Pharmaceuticals Inc (MRNS) - Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2022 Financial Results.
Qtrly Total Revenue $2.3 Million.
Qtrly EPS $1.89.
Q4 Earnings per Share View $-0.98, Revenue View $8.1 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $8.55 Million
Adjusted EPS is expected to be -$0.61

Next Quarter Revenue Guidance is expected to be $7.27 Million
Next Quarter EPS Guidance is expected to be -$0.72

More details on our Analysts Page.